Jingchun Zeng

Dr. Jingchun Zeng


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2018 in International Journal for Equity in Health
Verified
Journal Article
Open access
PDF file
LLLiming Lu
Liming Lu
JZJingchun Zeng
Jingchun Zeng
This study identifies inequities in the provincial-level geographical distribution of traditional Chinese Medicine (TCM) hospital beds and doctors in China from 2004 to 2014. This provides policy implications of the optimal allocation of TCM health care resources. Our study used province level data on TCM hospital beds and doctors from 2004 to 2014. These data were obtained from the China TCM Yearbook 2004–2014 and the China Statistical Yearbook 2004–2014.Global and local spatial autocorrelation was performed by using Moran’s index and the local Moran’s index to describe the spatial distribution of TCM hospital beds (doctors) as well as their density. A Gini coefficient was used to estimate inequalities in the geographic distribution of TCM hospital beds (doctors) based on their density. Correlations of the Gini coefficients between TCM hospital beds and doctors were calculated by Pearson correlation analysis. All indicators of TCM hospital beds and doctor density have increased over the past 11 years. The number of TCM hospital beds per 10,000 populations increased the fastest. Geographical clustering was not obvious in the density distribution of TCM hospital beds or doctors, as no significant spatial autocorrelation was found. Gini coefficients showed that from 2004 to 2014 the distribution of TCM hospital beds per 10,000 population and doctors per 10,000 populations were equitable between different regions. A large gap existed in the distribution inequality of TCM hospital beds (doctors) per square kilometer among different regions. Targeted health policy with equitable distribution of TCM hospital beds (doctors) per square kilometer and the balance and coordination of related resources should be a priority in shaping China’s healthcare system reform.

8 August 2025 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
LDLu Ding
Lu Ding
MZMeiling Zhang
Meiling Zhang
BFBaochao Fan
Baochao Fan
FDFuyuan Deng
Fuyuan Deng
ZLZhenyuan Li
Zhenyuan Li
LLLiming Lu
Liming Lu
Objective: To systematically collate and evaluate metabolomics-based biomarkers of ischemic stroke (IS) to guide clinical diagnosis and treatment.Methods: Comprehensive literature searches were conducted in PubMed, Embase, and Web of Science using “IS” and “metabolomics” as core keywords, covering publications up through February 2024. Any original metabolomic research related to IS was selected. Key information such as study demographics, study type, objectives, metabolomic analysis methods, and main findings were extracted and analyzed. Frequently mentioned metabolites were subjected to enrichment analysis using the MetaboAnalyst 6.0 platform.Results: A total of 51 studies were included. Quality assessment revealed that 54.8% of the diagnostic studies and 69.2% of the prognostic studies were high-quality, with most controlling for confounding factors. Metabolite analysis revealed associations between decreased proline, isoleucine, valine, and alanine levels with IS. Increased tyrosine, glutamine, phenylalanine, sphingomyelin, glutamate, lactate and glucose, and decreased LysoPC (18:2), histidine, and methionine levels were linked to IS onset. Specific metabolite combinations, such as serine, isoleucine, betaine, PC (5:0/5:0), and LysoPE (18:2), showed high precision in predicting acute ischemic stroke (AIS) (training set AUC = 0.988, test set AUC = 0.971). Glycine-serine-threonine and valine-leucine-isoleucine pathways were significant in diagnosing IS and AIS, and in differentiating ischemic and hemorrhagic strokes, as well as identifying post-stroke depression and cognitive impairment.Conclusion: This study confirms the potential diagnostic and prognostic value of changes in amino acids and lipids, as well as other metabolites and metabolic pathways, in IS. These findings highlight the promise of metabolomics in IS diagnosis, differential diagnosis, risk assessment, and complication identification. However, further validation is needed due to the varying quality of the included studies.Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/#myprospero, identifier CRD42022335505.

14 October 2021 in Integrative Medicine Research
Verified
Journal Article
Open access
CCChen Chen
Chen Chen
JZJie Zhan
Jie Zhan
HWHao Wen
Hao Wen
XWXiaojing Wei
Xiaojing Wei
LDLu Ding
Lu Ding
LLLiming Lu
Liming Lu
Since the outbreak of coronavirus disease (COVID-19), acupuncture has been widely used in the treatment of COVID-19. The research community has responded rapidly and has already published many research articles about this topic. We searched PubMed, Embase, Cochrane Library as well as CNKI, Wanfang and VIP from January 1, 2020 to July 31, 2021. The dates of publication, language of publication, methodological characteristics and the key findings were analyzed separately. The data are presented as bar graphs, structured tables and figures. In this scoping review, 16 research articles were included: 7 case reports, 6 observational studies, 1 review, 1 RCT and 1 nonrandomized clinical trial. The majority of the articles (81.3%) were published by Chinese scholars, 12.5% articles were by scholars in the United States, and 6.3% articles were by scholars in Iran. The included studies reported that acupuncture could alleviate the symptoms of COVID-19 patients, shorten their hospitalization days, and is effective for the elderly. There were no side effects reported. The most frequent acupoints used were LI4, PC6, ST36 and KI3. They reported many obstacles in implementing acupuncture therapy for treating COVID-19 patients. Acupuncture has a good effect for the treatment of COVID-19, but high-quality evidence support is still lacking. Coupled with the difficulties that acupuncturists experienced during the process of treatment, the promotion of acupuncture treatment for COVID-19 faces many obstacles.

1 July 2019 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
KLKun Liu
Kun Liu
JZJingchun Zeng
Jingchun Zeng
PWPei Wenya
Pei Wenya
SCSiyu Chen
Siyu Chen
ZLZhenke Luo
Zhenke Luo
GLGuohua Lin
Guohua Lin
Background: This study evaluates the reporting quality of randomized controlled trials (RCTs) on acupuncture use for the treatment of postherpetic neuralgia and explores related factors. Methods: The following six databases PubMed, Embase, Cochrane Library, VIP, CNKI, and SinoMed, were systematically searched from their inception to December 2018. RCTs using acupuncture as an intervention for postherpetic neuralgia were selected and incorporated in this study. The reporting quality was assessed based on the CONSORT statement and the STRICTA guidelines. Regression analyses were also conducted on pre-specified study characteristics searching for factors associated with reporting quality. Results: A total of 137 RCTs were included in this study. The CONSORT based median OQS was 12 (minimum 3, maximum 29). Of the items comprised in the statement, ten were sufficiently reported (reported in over 70% of trials). The remaining fifty-five items were poorly reported (reported by fewer than 5% of trials). The STRICTA based median OQS was 9 (minimum 2, maximum 15). The results showed that eight of the comprised items were well reported (reported in over 70% of trials), and only three were incompletely reported (reported in fewer than 20% of trials). Based on the CONSORT statement related analysis, a post-2010 publication (β coefficient 2.394, 95% confidence interval [CI] 1.168–3.620) and funding (β coefficient 4.456, 95% CI: 3.009–5.903) represented independent and significant predictors of a high overall reporting quality. However, only a funding source (β coefficient 1.305, 95% CI 0.219–2.391) was associated with an increased OQS based on STRICTA analysis. Conclusion: The findings indicated that RCTs on acupuncture for PHN generally had a sub-optimal reporting quality, a situation that improved for those published after 2010 or with funding sources. Therefore, rigorous adherence to the CONSORT statement and the STRICTA guidelines should be emphasized in future studies.

20 January 2026 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
MYMengyu Yang
Mengyu Yang
XCXuanrui Chen
Xuanrui Chen
SLShiyin Lie
Shiyin Lie
JLJingjing Li
Jingjing Li
XCXuezhang Chen
Xuezhang Chen
JZJingchun Zeng
Jingchun Zeng
Objective: This study employs a dual-metric framework integrating bibliometric and altmetric analyses to systematically map the knowledge domain and structural evolution of P2Y receptor research in cardiovascular diseases (CVDs) from 2005 to 2025. Methods: Data were systematically retrieved from the Web of Science Core Collection, Scopus, PMC, and Altmetric databases. By integrating network visualization (CiteSpace, VOSviewer), descriptive bibliometrics, and qualitative content analysis, this study mapped the structural evolution of the research landscape. Additionally, the correlation between scholarly impact and social visibility was quantified using Spearman analysis. Results: Our analysis encompassed 2,591 articles published between 2005 and 2025, from which the top 100 based on citation count and Altmetric Attention Score (AAS) were selected. The annual publication volume demonstrates sustained growth. The USA contributed 941 articles and holds a leading position, with scholars such as Dominick J. Angiolillo (132 articles) forming a core collaborative network focused on the clinical translation of P2Y 12 antagonists. High-impact journals (Impact Factor >5) accounted for 80% of the publications, indicating a strong clinical orientation; the Journal of the American College of Cardiology received the most citations. The research focus has shifted from the antithrombotic mechanisms of early P2Y 12 inhibitors like clopidogrel toward immune inflammation, myocardial regeneration, and precision medicine. Altmetric Attention Scores showed a high correlation with social media attention but only a moderate correlation with academic citations, whereas Mendeley readership correlated strongly with citations, revealing a divergence between social visibility and scholarly impact. Conclusion: P2Y receptor research has transformed from a singular antithrombotic focus into a multidimensional regulatory network. While P2Y 12 antagonists remain clinically dominant, emerging frontiers focus on “de-escalation” strategies, immune-inflammation, and myocardial regeneration. Future progress relies on systematic evaluation of subtype selectivity and novel delivery systems, positioning P2Y receptor modulation as a promising avenue for precision cardiovascular medicine.

12 October 2024 in Integrative Medicine Research
Verified
Journal Article
Open access
SHShanshan Huang
Shanshan Huang
YWYuting Wang
Yuting Wang
YWYifan Wu
Yifan Wu
PHPuchen Huang
Puchen Huang
YDYu Dong
Yu Dong
XLXinxia Liu
Xinxia Liu
Assess the safety and effectiveness of acupuncture for acute ischemic stroke (AIS). We conducted a comprehensive search across the PubMed, Cochrane Library, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), Wanfang, and SinoMed databases from their inception until October 3, 2023. Two reviewers screened eligible randomized controlled trials (RCTs) according to criteria and extracted data using a pre-established form. Cochrane tool was used for risk of bias assessment, and Revman 5.3 was used for subsequent meta-analysis. The GRADE tool will be used to assess the quality of evidence. Thirty-one RCTs were included, involving 3604 patients. Meta-analysis showed that compared with conventional treatments (CTs), acupuncture combined with CTs could improve in National Institutes of Health Stroke Scale (NIHSS) and Efficiency (MD:1.70, 95 %CI [-2.27, -1.14], P < 0.00001;RR: 1.21, 95 %CI [1.12, 1.31], P < 0.00001,);On the Chinese Stroke Scale (CSS) and effectiveness based on CSS, acupuncture showed positive effects (MD:4.33, 95 %CI [-5.67, -2.98], P < 0.00001; RR: 1.26, 95 %CI [1.13, 1.41], P < 0.0001). Furthermore, ADL, Fugl-Meyer Assessment Scale (FMA), prognosis analyses also showed the effectiveness of acupuncture. (SMD: 0.98, 95 % CI [0.64, 1.31], P < 0.00001; MD: 16.46, 95 %CI [12.56, 20.35], P < 0.00001; RR: 0.38, 95 %CI [0.16, 0.89], P = 0.03). However, the certainty of evidence was low. According to current evidence, Acupuncture may be effective and safe for AIS. The future still needs high-quality evidence to support this conclusion.